Who we are
Swiss based company, specialized in the discovery, clinical validation and commercialization of point-of-care diagnostics with advanced blood-based biomarkers for brain injuries

What we do
ABCDx develops a portfolio of diagnostic tools for brain diseases. The most advanced programme is TBI check, a user-friendly diagnostic test, allowing Health care professionals (HCPs), Sport & military organizations to better detect patients with mild traumatic brain injury (TBI).

ABCDx Partnering opportunities
ABCDx has secured exclusive rights of biomarkers in the field of brain injuries from re-known Universities and Research centres. The company has a wide portfolio of patents and clinical validation in the field of :

Detection of mild Traumatic Brain Injuries
Differentiation between ischemic and haemorrhagic stroke
Selecting LVO stroke patients for rapid treatment
Evaluation of mild TBI patient outcomes

In order to accelerate market access in some territories and segments, ABCDx is seeking for the best partners to offer its exclusive break-through innovations to patients at the earliest, with optimum quality.

ABCDx software

BRAINCheck - App